Innovating Works

Bering

Desconocido
Athero-B-Cell: Targeting and exploiting B cell functions for treatment in cardiovascular disease BERING LIMITED participó en un FP7: Cardiovascular disease (CVD) mortality and morbidity is predicted to increase in Europe and worldwide in the next decades due to aging and t...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.